Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs6601049 | chr5:178982665 | G/A | 9.11E-7 | 131 | 41.97 | 43.02 | 73.72 | KM Plot |
| TGCT | rs6651216 | chr8:116874954 | A/C | 7.29E-7 | 134 | 45.1 | 28.87 | 18.83 | KM Plot |
| TGCT | rs66540114 | chr7:128720295 | G/A | 1.67E-5 | 134 | 42.27 | 31.17 | 17.1 | KM Plot |
| TGCT | rs66595118 | chr9:37056194 | C/T | 3.49E-5 | 130 | 35.37 | 65.05 | 45.1 | KM Plot |
| TGCT | rs66619975 | chr4:47471076 | ATCT/A | 0.000134 | 133 | 45.47 | 36.63 | 51.6 | KM Plot |
| TGCT | rs66872377 | chr7:128722172 | A/C | 1.67E-5 | 134 | 42.27 | 31.17 | 17.1 | KM Plot |
| TGCT | rs66937140 | chr7:53293928 | GAGATGGCCCCTTCT/G | 3.28E-13 | 130 | 41.33 | 43.53 | 8.6 | KM Plot |
| TGCT | rs66954515 | chr3:172407699 | A/ATT | 2.56E-5 | 128 | 45.1 | 37.62 | 25.8 | KM Plot |
| TGCT | rs67077163 | chr8:125587162 | C/A | 1.92E-5 | 132 | 41.97 | 46.77 | 22.68 | KM Plot |
| TGCT | rs67162942 | chr6:42671861 | AT/A | 5.05E-6 | 128 | 38.2 | 49.93 | 23.82 | KM Plot |
| TGCT | rs6739099 | chr2:54823310 | G/A | 6.44E-5 | 131 | 46.3 | 44.05 | 22.42 | KM Plot |
| TGCT | rs67395401 | chr10:27573976 | A/G | 2.11E-12 | 129 | 42.27 | 45.83 | 20.6 | KM Plot |
| TGCT | rs67457439 | chr2:54837729 | A/T | 6.89E-5 | 131 | 45.1 | 44.05 | 22.42 | KM Plot |
| TGCT | rs67536526 | chr4:58371946 | TTGC/T | 0 | 133 | 42.1 | 53.83 | 0.5 | KM Plot |
| TGCT | rs67548443 | chr2:3487332 | A/ACTC | 2.43E-5 | 131 | 40.57 | 66.17 | 25.32 | KM Plot |